Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > Europe
Category: All Categories > Life Sciences > Pharmaceuticals > Country Overviews
(163 reports matching your criteria)
1  2    4    6  7  
Pharmaceuticals in Spain: ISIC 2423
4/18/2013 | published by: Euromonitor International
... at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing ...  |  read more...
USD 600
Pharmaceuticals in United Kingdom: ISIC 2423
1/15/2013 | published by: Euromonitor International
... the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new ...  |  read more...
USD 600
Pharmaceuticals in France: ISIC 2423
12/18/2012 | published by: Euromonitor International
... the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new ...  |  read more...
USD 600
Intellinews - Polish Pharmaceutical Sector Report - October 2012
11/2/2012 | published by: Intellinews
... comments. This sector report is ideal to keep you abreast on recent company and industry news. Written by local professionals, it is a unique market and business intelligence analysis, tailored to save time by providing ...  |  read more...
USD 240
Pharmaceuticals in Italy:ISIC 2423
9/25/2012 | published by: Euromonitor International
... the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new ...  |  read more...
USD 600
Moldova Pharmaceuticals and Healthcare Q4 2012
9/19/2012 | published by: Business Monitor International
... sizeable local manufacturers, imported pharmaceuticals dominate themarket. Despite intervention by the prime minister, medicine price inflation is a common problem,leaving many patients unable to afford medication that is not covered by the mandatory health insurancescheme. ...  |  read more...
USD 1,175
Portugal Pharmaceuticals and Healthcare Q4 2012
9/19/2012 | published by: Business Monitor International
... industry. Delayed payments are commonplace, with the impact feltthroughout the supply chain, and this is reducing Portugal’s appeal to multinationals: Roche hassuspended drug supplies to some public hospitals and press reports suggest that Merck KGaA ...  |  read more...
USD 1,175
Belarus Pharmaceuticals and Helathcare Report Q3 2012
8/8/2012 | published by: Business Monitor International
... may keep it ticking over. However,aside from some public statements about Chinese and Indian investments, which BMI regards withscepticism, foreign pharmaceutical players will stay out of Belarus until the economy reaches a newequilibrium. In addition, ...  |  read more...
USD 1,175
Greece Pharmaceuticals and Healthcare Q3 2012
7/17/2012 | published by: Business Monitor International
... our assessment of the pharmaceutical and healthcare market, as this vote was widely seen as a proxy vote of eurozone membership. Following the result, we maintain our core forecast scenario of continued austerity. Indicators that ...  |  read more...
USD 1,175
The Pharmaceutical Market: Poland
5/15/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
The Pharmaceutical Market: Germany
5/14/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
The Pharmaceutical Market: Croatia
5/14/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
Pharmaceuticals – Czech Republic – a snapshot (2011)
4/19/2012 | published by: Mintel - Snapshots
... as hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Czech Republic is given in %, CZK and USD with a minimum of five years' ...  |  read more...
USD 600
Pharmaceuticals – Slovak Republic – a snapshot (2011)
4/10/2012 | published by: Mintel - Snapshots
... as hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Slovak Republic is given in %, EUR and USD with a minimum of five years' ...  |  read more...
USD 600
Pharmaceuticals – UK – a snapshot (2011)
4/5/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in UK is given in %, GBP and USD with a minimum of five years' historical data. ...  |  read more...
USD 600
Pharmaceuticals – Poland – a snapshot (2011)
3/23/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Poland is given in PLN with a minimum of five years' historical data. Market Forecast is ...  |  read more...
USD 600
Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates
2/29/2012 | published by: GBI Research
... Growth Rates” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in the Czech Republic. The report analyzes overall pharmaceutical and outsourcing market structure in the Czech Republic. The report provides competitive ...  |  read more...
USD 3,500
Pharmaceuticals – Sweden – a snapshot (2011)
2/29/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Sweden is given in SEK with a minimum of five years' historical data. Market Forecast is ...  |  read more...
USD 600
Pharmaceuticals – France – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in France is given in EUR with a minimum of five years' historical data. Market Forecast is ...  |  read more...
USD 600
The Outlook for Pharmaceuticals in Western Europe (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... market. Growth, however, will be tempered somewhat by the effects of the global economic recession in the short term. The leading markets are projected to average a CAGR of 2.1% in US dollar terms up ...  |  read more...
USD 3,630
The Pharmaceutical Market: Bulgaria (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
The Pharmaceutical Market: Sweden (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
The Pharmaceutical Market: Switzerland (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
The Pharmaceutical Market: Estonia (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
The Pharmaceutical Market: Croatia (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
USD 1,085
1  2    4    6  7